Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ACTIVE PHARMACEUTICAL INGREDIENTS INDUSTRY
2.1 Summary about Active Pharmaceutical Ingredients Industry
2.2 Active Pharmaceutical Ingredients Market Trends
2.2.1 Active Pharmaceutical Ingredients Production & Consumption Trends
2.2.2 Active Pharmaceutical Ingredients Demand Structure Trends
2.3 Active Pharmaceutical Ingredients Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Synthetic APIs
4.2.2 Biotech APIs
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 CNS
4.3.2 Cardiovascular
4.3.3 Genitourinary/Hormonal Drugs
4.3.4 Respiratory
4.3.5 Rheumatology
4.3.6 Diabetes
4.3.7 Oncology
4.3.8 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Synthetic APIs
5.2.2 Biotech APIs
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 CNS
5.3.2 Cardiovascular
5.3.3 Genitourinary/Hormonal Drugs
5.3.4 Respiratory
5.3.5 Rheumatology
5.3.6 Diabetes
5.3.7 Oncology
5.3.8 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Synthetic APIs
6.2.2 Biotech APIs
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 CNS
6.3.2 Cardiovascular
6.3.3 Genitourinary/Hormonal Drugs
6.3.4 Respiratory
6.3.5 Rheumatology
6.3.6 Diabetes
6.3.7 Oncology
6.3.8 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Synthetic APIs
7.2.2 Biotech APIs
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 CNS
7.3.2 Cardiovascular
7.3.3 Genitourinary/Hormonal Drugs
7.3.4 Respiratory
7.3.5 Rheumatology
7.3.6 Diabetes
7.3.7 Oncology
7.3.8 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Synthetic APIs
8.2.2 Biotech APIs
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 CNS
8.3.2 Cardiovascular
8.3.3 Genitourinary/Hormonal Drugs
8.3.4 Respiratory
8.3.5 Rheumatology
8.3.6 Diabetes
8.3.7 Oncology
8.3.8 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Synthetic APIs
9.2.2 Biotech APIs
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 CNS
9.3.2 Cardiovascular
9.3.3 Genitourinary/Hormonal Drugs
9.3.4 Respiratory
9.3.5 Rheumatology
9.3.6 Diabetes
9.3.7 Oncology
9.3.8 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Teva
10.1.2 Mylan
10.1.3 DSM
10.1.4 Aurobindo Pharma
10.1.5 Aspen
10.1.6 Novartis
10.1.7 BASF
10.1.8 Pfizer
10.1.9 Huahai Pharmaceutical
10.1.10 Hisun Pharmaceutical
10.1.11 Sun Pharmaceutical Industries
10.1.12 Zhejiang Medicine
10.1.13 Dr. Reddy\'s Laboratories
10.1.14 Zhejiang NHU
10.1.15 Bayer
10.1.16 NCPC
10.1.17 AbbVie
10.1.18 Shandong Xinhua Pharmaceutical
10.1.19 Northeast Pharm
10.1.20 Harbin Pharmaceutical
10.1.21 LKPC
10.2 Active Pharmaceutical Ingredients Sales Date of Major Players (2017-2020e)
10.2.1 Teva
10.2.2 Mylan
10.2.3 DSM
10.2.4 Aurobindo Pharma
10.2.5 Aspen
10.2.6 Novartis
10.2.7 BASF
10.2.8 Pfizer
10.2.9 Huahai Pharmaceutical
10.2.10 Hisun Pharmaceutical
10.2.11 Sun Pharmaceutical Industries
10.2.12 Zhejiang Medicine
10.2.13 Dr. Reddy\'s Laboratories
10.2.14 Zhejiang NHU
10.2.15 Bayer
10.2.16 NCPC
10.2.17 AbbVie
10.2.18 Shandong Xinhua Pharmaceutical
10.2.19 Northeast Pharm
10.2.20 Harbin Pharmaceutical
10.2.21 LKPC
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
